Valeant Pharmaceuticals

I Dont Want To Get Rid Of My Psoriasis
Health

Valeant Stock Was Having a Pretty Good 2018—Until Today

By
June 18, 2018
Cosmopolitan: Let's Talk About It Event
Finance

Valeant Is Paying to Get Rid of Its $1 Billion ‘Female Viagra’ Acquisition

By
November 7, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli Case Nears End As Lawyers Prepare For Final Argument
Tech

A New ICO Wants to Get That Wu-Tang Album Out of Martin Shkreli’s Hands

By
September 25, 2017
Joe Biden Spars With Bill Ackman
Finance

Joe Biden Spars With Bill Ackman

By
June 24, 2017
Bill Ackman herbalife
Finance

Bill Ackman Lost $7.7 Million Per Day on Valeant Stock

By
March 15, 2017
Trading At The NYSE As Valeant Shares Halted Ahead of News Announcement
Finance

Valeant’s Debt Refinance Will Go On Without Bill Ackman

By
March 14, 2017
Ackman, founder and CEO of hedge fund Pershing Square Capital Management, speaks to audience in New York
Finance

Bill Ackman’s Valeant Exit Is an Enormous Loss for the Faded Hedge Fund Star

By
March 13, 2017
Squawk Box - Season 20
Health

This Investor Says Hedge Funds’ Bets on Valeant Were Worse Than Enron

By
November 17, 2016
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
Health

Valeant Is Being Sued Over the ‘Female Viagra’ Pill

By Reuters and Tekendra Parmar
November 3, 2016
Valeant Pharmaceuticals Offices Ahead Of Earnings Figures
Finance

Valeant Is Said to Be Hiring This Zoetis Exec as Its New CFO

By Reuters and Michelle Toh
August 22, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Health

T. Rowe Price Sues Valeant Over Alleged Fraud

By
August 18, 2016
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
Finance

Valeant’s Troubles Aren’t Driving It To Lower Drug Prices

By
August 9, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Health

New Valeant CEO Meets Investors Amid Company Struggles

By
June 14, 2016
Yellen Speaks, California Votes, and Valeant Reports—5 Things to Look For in the Week Ahead
Features

Yellen Speaks, California Votes, and Valeant Reports—5 Things to Look For in the Week Ahead

By
June 5, 2016
Pershing Square's Bill Ackman and Valeant Pharmaceuticals International's Michael Pearson Interview
Finance

Valeant’s Former CEO Will Stay on as an $83,000-a-Month Consultant

By
May 31, 2016

Most Popular